Can bacteria produce electricity?


Can bacteria produce electricity?
The depletion of fossil fuel reserves, global warming, energy security and the need for clean, cheap fuels has made developing sources of renewable energy a global research priority. Microbial Fuel Cells (MFCs) have the potential to generate renewable electricity from a vast array of carbon sources such as waste-water, agricultural by-products and industrial pollutants. MFCs are not yet commercialized but they show great promise as a method of water treatment and as power sources for environmental sensors and are the promising factors for future. The power produced by these systems is currently limited, primarily by high internal (ohmic) resistance.   The optimization of MFC systems is a highly multidisciplinary area of research and two complementary areas of work are required - firstly to design more efficient hardware for the cells by traditional engineering and secondly to understand and improve the interaction and electron transport between microbes and electrode via biological engineering. 
One of the most important engineering challenges in MFC development is the efficient electron transfer from the bacteria to the anode. To date three possible methods of transferring electrons from bacterial cells to the electrode have been identified - directly via cell surface cytochromes ( Shewanella spp), via pilli acting as nanowires (Geobacter spp) or via the production of soluble electron mediator compounds (e.g. Pseudomonas sp phenazine production). Fundamental to cell contact with the anode, electron transfer and thus the functioning of the MFC is the formation of specialized biofilms on the electrode surface. It has been shown that the power output of MFCs and that the power density was directly dependent on biofilm growth and composition.


We are using a genetic engineering approach to reengineer bacteria to certainly and efficiently generate and transfer electrons to microbial fuel cell electrodes resulting in a highly versatile, reliable and sustainable energy sources. We aim to -
1.     Create a synthetic biology toolbox of biological parts and devices for the easy engineering of electrogenic microbial strains and the construction of genetic circuits for enhanced electron transfer capabilities.
2.     Investigate the structure, composition and activities of electrode biofilms.
3.     The versatility of carbon metabolism in the bacteria will be engineered to expand the range and efficiency of utilising pollutants as carbon sources for electricity generating metabolism closing the waste - energy loop. 

For more details visit the link: https://bacteriology.infectiousconferences.com/


Comments

Post a Comment

Popular posts from this blog

Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism

Image
Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism: The worldwide spread of anti-toxin resistant sexually transmitted diseases (STD) has received increased consideration in the course of recent years from health institutes including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). In this post we will give a background marked by multidrug-safe Neisseria gonorrhoeae taken after by a depiction of the test techniques clinical labs are utilizing to decide the antimicrobial susceptibilities of N. gonorrhoeae isolates. About Gonorrhea Gonorrhea is a worldwide widespread disease caused by N. gonorrhoeae, a Gram-negative bacterium. As per CDC, roughly 470,000 new gonorrheal diseases were accounted for. Notwithstanding, on the grounds that numerous cases are asymptomatic, and consequently unreported, it is evaluated that there are roughly 820,000 new cases every year. Furthermore, it is assessed that 246,000 of these cases conv
Read more

The antibiotic that is active against drug-resistant tuberculosis:

Image
The antibiotic that is active against drug-resistant tuberculosis:  A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.  The compound, kanglemycin A, is related to the antibiotic rifampicin, according to Katsuhiko Murakami, professor of biochemistry and molecular biology at Penn State and one of leaders of the project. "Rifampicin is already part of the cocktail of antibiotics used to treat tuberculosis, but many strains of the tuberculosis-causing bacteria have developed resistance to it," Murakami said. "Tuberculosis is the leading cause of death by infectious disease worldwide," said Murakami. "Development of rifampicin resistance in M. tuberculosis has m
Read more

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

Image
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug... Another and promising class of synthetic mixes has the noteworthy potential for treating Zika disease and respiratory syncytial infection, or RSV, according to another examination by University of Alberta scientists. The accompanying stage is to develop a medication. "This is both a wonderful scientific discovery and something that can possibly emphatically influence worldwide wellbeing as well as the economy of Canada," said Fred West, professor in the Department of Chemistry who led the new discovery along with David Marchant. The compound is alike isatisine A which is an antiviral compound usually found in traditional Chinese herbal medicine. Hobman is a professor of cell biology and a specialist in the Zika virus, a pathogen that can
Read more